$PFE Headlines Pfizer's Rapamune doesn't meet primary

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2013 at 1:26 PM

$PFE Headlines

Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
The Next 24: Apple Angst, India Rate Hike 5:40 p.m. Oct. 28, 2013 - MarketWatch
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
At the NYSE, Larry Kofsky looks at the week ahead 7:01 a.m. Oct. 27, 2013 - MarketWatch
What Google and Netflix are telling us 12:37 p.m. Oct. 24, 2013 - Mark Hulbert

Pfizer And Merck Continue To Battle Declining Revenue 11:49 a.m. Today - Seeking Alpha
10-Q: PFIZER INC 3:45 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
Alcoa Backs London Metal Exchange Up to a Point and 2 Other Hot Stocks to Watch 1:44 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
107-Year Old Irving Kahn Buys BP, BlackBerry, New York Community Bancorp, Sells SLM, Seaboard, ... 10:30 a.m. Nov. 8, 2013 - GuruFocus.com
AbbVie's Not as Vulnerable as the Street Believes 6:30 a.m. Nov. 8, 2013 - TheStreet.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Irving Kahn's High-Impact Sells in Third Quarter 5:22 p.m. Nov. 7, 2013 - GuruFocus.com
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
Wal-Mart Blames Tech Glitch for Temporary Weird Prices and 2 Other Dow Movers to Watch 1:38 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
U.S. Launch of Actelion's Opsumit - Analyst Blog 4:30 p.m. Nov. 5, 2013 - Zacks.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Marginal Earnings Miss at Zoetis in Q3 - Analyst Blog 4:19 p.m. Nov. 5, 2013 - Zacks.com
FDA Okays Pfizer’s Embeda Extended Release Capsules and 2 Other Hot Stocks to Watch 2:10 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - CFN, PFE, IACI, GMED And TUP Traded By Insiders 12:16 p.m. Nov. 5, 2013 - TheStreet.com

Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
Critical Stock Analysis: Pfizer, Barrick Gold Corporation, Micron Technology, Wells Fargo, Zynga 8:50 a.m. Nov. 1, 2013 - PR Newswire
Pain Therapeutics Reports Q3 2013 Financial Results 8:00 a.m. Oct. 31, 2013 - GlobeNewswire
NLY, BAC, DDD and PFE added to NYSE Active Stock Watch List at GSR 9:28 a.m. Oct. 29, 2013 - ACCESSWIRE
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
Pfizer Reports Third-Quarter 2013 Results 7:00 a.m. Oct. 29, 2013 - BusinessWire
Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca 9:00 a.m. Oct. 28, 2013 - PR Newswire
Nodality, Inc. Announces Presentations at 2013 American College of Rheumatology Annual Meeting 7:30 a.m. Oct. 28, 2013 - BusinessWire
Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk 6:00 a.m. Oct. 28, 2013 - BusinessWire
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend 4:00 p.m. Oct. 24, 2013 - BusinessWire
TherapeuticsMD Appoints Sebastian Mirkin, M.D. as Chief Medical Officer 7:57 a.m. Oct. 23, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insilico Joins HKEX Tech 100: AI and Pharma Synergies

Insilico Medicine just locked down a spot in the HKEX Tech 100 Index, and that's a pretty big deal, if you ask me. This Cambridge-based outfit is making waves with its generative AI wizardry in drug discovery. It's not just about earning a tech badge of honor here; it's about opening doors to new investors and bolstering liquidity. When changes hit on September 14, 2026,...

Aurzen's ZIP Pro: A Mobile Cinema Revolution?

Aurzen ZIP Pro: A Big Splash in Times Square In the bustling heart of Manhattan, the glitz and glam of Times Square will shine a bit brighter this Fall. Why? Because Aurzen's introducing their latest gadget, the ZIP Pro. It’s a tri-fold Full HD pocket projector that, frankly, is aiming to redefine portable viewing. Boasting the ability to unfurl an 80-inch...

Ace Hardware Hits 100th Store Milestone, Talks Growth

Ace Hardware Signals Expansion Through 100th Store Anyone eying the hardware retail landscape knows that Ace Hardware is not just coasting through another predictable quarter. No, this coop, fondly dubbed the helpful hardware folks, has just cranked open the doors on its 100th new store of 2026. Yep, they're charging full-throttle on their expansion strategy, determined...

Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Texas Institute Leads Trailblazing Arrhythmia Study

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

K-Royal Culture Festival 2026: A Global Heritage Experience

The K-Royal Culture Festival is rolling out in Fall 2026 with a flair that promises to capture the globetrotters' imaginations and then some. South Korea's signature national heritage jamboree is popping off from October 7 through October 11, 2026, at four magnificent palaces and the Jongmyo Shrine. If you're into discovering the depths of a place's history through...

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Viventium's New Healthcare Platform: A Game Changer

Revolution in Workforce Management for Healthcare When a healthcare company like Viventium decides to expand its human capital management (HCM) platform, you've got to sit up and take notice, especially in a field that's been biting its nails over workforce headaches for years. Staffing shortages, growing compliance hurdles, and labor costs squeezing tighter than...

Tahoe Truckee Life TV Series Elevates Local Flavor

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...